Genolution Inc. (225220) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, Genolution Inc. (225220) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-927.21 Million ≈ $-628.35K USD) by net assets (₩73.39 Billion ≈ $49.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Genolution Inc. to measure how much of total assets are equity-financed.

Genolution Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Genolution Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Genolution Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Genolution Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genolution Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Khind Holdings Bhd KLSE:7062	0.064x
Telefield Inc KQ:091440	-0.094x
Edaran Bhd KLSE:5036	-0.606x
PRI EKOPARK SA ZY -10 F:NPA	0.542x
Hanchang KO:005110	0.818x
FINEDIGITAL Inc KQ:038950	0.008x
Visionary Gold Corp V:VIZ	-0.015x
Berkosan Yalitim ve Tecrit Maddeleri Uretim ve Ticaret AS IS:BRKSN	-0.044x

Annual Cash Flow Conversion Efficiency for Genolution Inc. (2016–2024)

The table below shows the annual cash flow conversion efficiency of Genolution Inc. from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Genolution Inc..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩80.29 Billion ≈ $54.41 Million	₩-1.43 Billion ≈ $-970.93K	-0.018x	-37.43%
2023-12-31	₩87.45 Billion ≈ $59.26 Million	₩-1.14 Billion ≈ $-769.54K	-0.013x	-109.07%
2022-12-31	₩94.70 Billion ≈ $64.18 Million	₩13.55 Billion ≈ $9.18 Million	0.143x	-54.29%
2021-12-31	₩82.20 Billion ≈ $55.71 Million	₩25.73 Billion ≈ $17.44 Million	0.313x	-58.26%
2020-12-31	₩61.29 Billion ≈ $41.54 Million	₩45.97 Billion ≈ $31.15 Million	0.750x	+2556.06%
2019-12-31	₩2.64 Billion ≈ $1.79 Million	₩-80.58 Million ≈ $-54.61K	-0.031x	-160.85%
2018-12-31	₩2.94 Billion ≈ $1.99 Million	₩147.49 Million ≈ $99.95K	0.050x	-72.00%
2017-12-31	₩4.00 Billion ≈ $2.71 Million	₩717.13 Million ≈ $485.99K	0.179x	+2372.91%
2016-12-31	₩3.42 Billion ≈ $2.32 Million	₩-27.00 Million ≈ $-18.30K	-0.008x	--

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$15.82 Million

₩23.34 Billion KRW

Market Cap Rank

#25788 Global

#1919 in Korea

Share Price

₩1292.00

Change (1 day)

-0.31%

52-Week Range

₩1030.00 - ₩2590.00

All Time High

₩10300.23